Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹892 Cr₹1,005 Cr₹484 Cr₹766 Cr₹598 Cr

What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA is ₹892 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹892 Cr
Mar2024₹1,005 Cr
Mar2023₹484 Cr
Mar2022₹766 Cr
Mar2021₹598 Cr

How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹892 Cr
-11.17
Mar2024 ₹1,005 Cr
107.60
Mar2023 ₹484 Cr
-36.86
Mar2022 ₹766 Cr
28.25
Mar2021 ₹598 Cr -

Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹18,136.9 Cr 2.6% -15.2% -34.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.6%

-15.2%

-34.5%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses